COPENHAGEN, Denmark – February 26, 2026. Novonesis delivered strong organic sales growth of 7% and an adjusted EBITDA margin of 37.1% in 2025. The company expects a good start to 2026 and a good year ...

Novonesis delivered strong organic sales growth of 7% and an adjusted EBITDA margin of 37.1% in 2025. The company expects a good start to 2026 and a good year overall. Ester Baiget, President & ...

Little time has passed since Novonesis officially came into being. The result of a merger between Denmark’s Chr Hansen and Novozymes, Novonesis aims to ‘unlock the limitless potential of biosolutions’ ...

For the first quarter as Novonesis, the company delivers 4% organic sales growth in line with expectations. Novonesis maintains the 2024 outlook of 5-7% organic sales growth with an adjusted EBITDA ...

Novonesis A/S – Adr ((NVZMY)) has held its Q4 earnings call. Read on for the main highlights of the call. Novonesis A/S used its latest earnings call to underline a broadly upbeat story of profitable ...

Novonesis was born less than a year ago from a merger between Novozymes and Chr. Hansen. The company specialises in ‘biosolutions’, essentially biological products used for functionality. In food and ...

Thank you very much, operator, and welcome, everyone, to the Novonesis Conference Call for the First Quarter of 2025. My name is Tobias Björklund, and as said, I'm heading up our Investor Relation ...

This will mark my first coverage of the company that was Chr. Hansen (CRTSF) and became Novonesis (NVZMY). In my article where I covered the merger, and also suggested a share price for the company ...

COPENHAGEN, Denmark – May 8, 2025. The global leader in biosolutions, Novonesis, had a strong start to its financial year with organic sales growth of 11% and an adjusted EBITDA margin of 38.3%. The ...

The Plant Base is the go to B2B news platform for the plant-based food and beverage industry. Refreshment is your ultimate resource for staying informed and up-to-date on the water cooler, vending, ...